Newsmeme!
Discover News you didn't know existed
Pharynx
News
Related Video News
No related video news stories found.
Related Videos
No related videos found.
Drugs not suspected in one of three Hamilton deaths
Published December 3, 2008, 10:18 pm, The Trentonian
HAMILTON — The circumstances surrounding one of three recent deaths of young women in the township became less clouded yesterday, as a medical examiner’s report seems to indicate the sudden loss was unrelated to the other two victims or to illicit drugs.
Annual Report to the Nation Finds Declines in Cancer Incidence and Death Rates; Special Feature Reveals Wide ...
Published December 2, 2008, 11:17 am, Centers for Disease Control and Prevention
A new report from the nation’s leading cancer organizations shows that, for the first time since the report was first issued in 1998, both incidence and death rates for all cancers combined are decreasing for both men and women, driven largely by declines in some of the most common types of cancer...
Merck's Erbitux receives EC approval for head & neck cancer
Published December 1, 2008, 7:50 pm, PharmaBiz
Merck KGaA and its Merck Serono division announced that it has received approval from the European Commission to extend the use of its targeted therapy Erbitux (cetuximab) to include first-line treatment of patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck (SCCHN). Erbitux was previously approved for use in combination with radiotherapy for locally advanced ...
Testing Deer Heads for Disease | Video
Published December 1, 2008, 6:33 pm, KFYR-TV Bismarck
Deer hunters have a lot of success stories to tell about the season that ended last month. Out of 140,000 licenses sold, about 80-percent of the tags were filled.
Merck Serono: European Commission Approves Erbitux For 1st-Line Use In Head And Neck Cancer
Published December 1, 2008, 6:12 am, Medical News Today
Merck Serono, a division of Merck KGaA, announced today that it has received approval from the European Commission to extend the use of its targeted therapy Erbitux® (cetuximab) to include 1st-line treatment of patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck (SCCHN).
My Pharmiweb.com
Published December 1, 2008, 2:03 am, PharmiWeb
Darmstadt, December 1, 2008 – Merck Serono, a division of Merck KGaA, announced today that it has received approval from the European Commission to extend the use of its targeted therapy Erbitux® (cetuximab) to include 1st-line treatment of patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck (SCCHN). Erbitux was previously approved for use in combination ...
Women Smokers Lose 14.5 Years Off Life Span
Published November 28, 2008, 12:06 am, HealthCentral
November is lung cancer awareness month, and doctors urge everyone to kick the habit.
Women Smokers Lose 14.5 Years Off Life Span
Published November 27, 2008, 9:14 pm, Washington Post
THURSDAY, Nov. 27 (HealthDay News) -- During Lung Cancer Awareness Month in November, female smokers should take advantage of available resources, pick a quit day, and start taking steps toward kicking the habit, urges The American College of Obstetricians and Gynecologists (ACOG).
Related News Resources:
> HGH News
News Directory
Get started fast by using a pre-defined news directory category
|
Breaking News
and Top Stories |
Business
Earnings, Economy, Personal Finance, and Stock Markets |
Entertainment
Books, Celebrity, Fashion, Movies, Music, Television, and Theatre |
Health
Aging, Diseases, Medical Conditions, Medications, Sexual Health, and Weight Loss |
Politics
Congress, Supreme Court, and White House |
|
Science
Animals, Astronomy, Biotechnology, Space, and Weather |
Sports
Baseball, Basketball, Boxing, Football, Golf, Hockey, Motor Sports, Soccer, and Tennis |
Technology
Communications, Hardware, Internet, Personal Technology, and Software |
United States
and Crimes and Trials |
World
Africa, Antartica, Asia, Australia, Canada, Europe, Latin America, and Middle East |